Podcasts about phd

Moral challenges have existed throughout history, and we all handle them in our own way. In today's Part 2 episode, Ryan continues his conversation with former NBA player turned psychologist John Amaechi. They discuss the ethical dilemmas that have endured for 2,000 years, the role of compromise, and the complexity of loyalty and sacrifice.John Amaechi is an English psychologist, consultant and former professional basketball player. He played college basketball for the Vanderbilt Commodores and Penn State Nittany Lions, and professional basketball in the NBA for the Orlando Magic, Utah Jazz, and Cleveland Cavaliers. Since retiring from basketball, John got his PhD in psychology and has worked as a psychologist and consultant, establishing his company Amaechi Performance Systems.Follow John on X @JohnAmaechi and on Instagram @JohnAmaechiOBE

After completing her PhD, Dr Fox took up a post-doctoral fellowship at NASA's Goddard Space Flight Centre in Maryland. In 2010, she became the project scientist for the Parker Solar Probe, humanity's first mission to a star.Shortly after she began working on the Parker Solar Probe project, she was away on work business when her husband died suddenly, leaving their very young children home alone. She told Lauren about that fateful day.You can listen to the full episode on BBC Sounds.

New details about the many reasons why ICE agents arrested and are preparing to deport "Dr." Ian Andre Roberts. I say "Dr" because the college where he mullegedly got his PhD has no record of him ever attending. The University of Tennessee holds a Christian revival that attracts 8,000 young people and leads to hundreds of baptisms and GOOD NEWS takes us to flood ravaged North Carolina where one man is determined to rebuild Chimney Rock.

Join Martin Willis in a groundbreaking conversation with Jensine Andresen, PhD, a scholar whose work bridges religion, philosophy, ethics, and the mysteries of UFO/UAP and extraterrestrial intelligence (ETI). In this interview, we explore: What “Acculturation with ETI” means and why it matters for humanity's future. How UAP and ETI discussions intersect with geopolitics, including the risks and realities tied to nuclear weapons. Why our current data-centric and militarized approach to the phenomenon may blind us to deeper truths. Why Dr. Andresen is adamant the visitors are extraterrestrial—and the theoretical mechanisms she believes could allow them to traverse the vast distances to reach us. The potential for creative engagement with ETI to transform human institutions, ethics, and global society. Dr. Andresen challenges conventional thinking and offers bold perspectives on how contact with ETI could reshape not only our science, but also our politics, spirituality, and collective future.SHOW NOTESSupport the Show & Stay Connected!

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: Sanofi lowers prices, oral pill for T1D prevention studied, updates from Medtronic, Tandem, and Sequel Med Tech, falsely lower A1Cs (and why that happens), Biolinq gets FDA okay for micro-needle CGM and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX French drugmaker Sanofi says it would offer a month's supply of any of its insulin products for $35 to all patients in the U.S. with a valid prescription, regardless of insurance status. The program, originally meant for uninsured diabetes patients, would now include those with commercial insurance or Medicare, the drugmaker said. Patients will be able to purchase any combination, type, and quantity of Sanofi insulins with a valid prescription for the fixed monthly price of $35, starting January 1. Lilly and Novo also have similar programs through which they offer insulin products for $35 a month for U.S. patients regardless of whether the patients have insurance. There is no law at work here – the only legislation that has changed the price of insulin came with the Inflation Reduction Act in 2022 with the Medicare cap. Helping lower the cost here, biosimilars hitting the market and the huge profitability for GLP-1 drugs for Novo and Lilly https://www.reuters.com/business/healthcare-pharmaceuticals/sanofi-offer-all-insulin-products-35-per-month-us-2025-09-26/ XX A pill typically prescribed for rheumatoid arthritis and alopecia might help slow the progression of type 1 diabetes, a new study says. Baricitinib (bare-uh-SIT-nib) safely preserved the body's own insulin production in people newly diagnosed with type 1 diabetes.. and their diabetes started progressing once they stopped taking baricitinib, results show. They produced less insulin and had less stable blood sugar levels.   Baricitinib works by quelling signals in the body that spur on the immune system, and is already approved for treating autoimmune conditions such as rheumatoid arthritis, ulcerative colitis and alopecia, researchers said.   “Among the promising agents shown to preserve beta cell function in type 1 diabetes, baricitinib stands out because it can be taken orally, is well tolerated, including by young children, and is clearly efficacious,” Waibel said. “We are hopeful that larger phase III trials with baricitinib are going to commence soon, in people with recently diagnosed type 1 diabetes as well as in earlier stages to delay insulin dependence,” she added. “If these trials are successful, the drug could be approved for type 1 diabetes treatment within five years.”   Findings presented at medical meetings should be considered preliminary until published in a peer-reviewed journal.   https://www.usnews.com/news/health-news/articles/2025-09-23/pill-effective-in-slowing-type-1-diabetes-progression XX An existing transplant drug has shown promise in slowing the progression of type 1 diabetes in newly diagnosed young people, potentially paving the way for the first therapy that modifies the disease after diagnosis. The Drug, called ATG, is currently used together with other medicines to prevent and treat the body from rejecting a kidney transplant. It can also be used to treat rejection following transplantation of other organs, such as hearts, gastrointestinal organs, or lungs. The researchers studied 117 people aged five to 25, who'd been diagnosed with type 1 diabetes within the past three to nine weeks. The participants were from 14 centers across eight European countries and were randomized to be given different doses of ATG (0.1, 0.5, 1.5, or 2.5 mg/kg) or a placebo. ATG was given as a two-day intravenous (IV) infusion. The main goal was to see how well the pancreas could still make insulin after 12 months, measured by C-peptide levels during a special meal test. C-peptide is released into the blood along with insulin by the pancreas.   The findings are promising, showing that ATG, even at a relatively low dose, can slow the loss of insulin-producing cells in young people newly diagnosed with type 1 diabetes. The lower dose also caused fewer side effects, making it a more practical option. https://newatlas.com/disease/antithymocyte-globulin-newly-diagnosed-type-1-diabetes/     XX The FDA has delayed its feedback on Lexicon Pharmaceuticals' application to bring Zynquista (sotagliflozin) to people with type 1 diabetes. The agency had planned to respond this month but will now wait until the fourth quarter after reviewing new data from ongoing studies. Zynquista, an oral drug meant to be used with insulin, has already been approved for heart failure (marketed as Inpefa). But in type 1 diabetes, it faces safety concerns: last year an FDA advisory committee voted 11–3 that its benefits don't outweigh the increased risk of diabetic ketoacidosis (DKA). The FDA later issued a complete response letter rejecting the drug. Lexicon is still pushing forward, hoping its additional submissions will strengthen Zynquista's case for type 1 diabetes approval. https://www.biospace.com/fda/after-fda-rejection-lexicons-type-1-diabetes-drug-hit-with-another-regulatory-delay     XX A common but often undiagnosed genetic condition may be causing delays in type 2 diabetes diagnoses and increasing the risk of serious complications for thousands of Black and South Asian men in the UK—and potentially millions worldwide. A new study found around one in seven Black and one in 63 South Asian men in the UK carry a genetic variant known as G6PD deficiency. Men with G6PD deficiency are, on average, diagnosed with type 2 diabetes four years later than those without the gene variant. But despite this, fewer than one in 50 have been diagnosed with the condition.   G6PD deficiency does not cause diabetes, but it makes the widely used HbA1c blood test—which diagnoses and monitors diabetes—appear artificially low. This can mislead doctors and patients, resulting in delayed diabetes diagnosis and treatment.   The study found men with G6PD deficiency are at a 37% higher risk of developing diabetes-related microvascular complications, such as eye, kidney, and nerve damage, compared to other men with diabetes.   "This study highlights important evidence that must be used to tackle these health inequalities and improve outcomes for Black communities. Preventative measures are now needed to ensure that Black people, especially men, are not underdiagnosed or diagnosed too late." https://medicalxpress.com/news/2025-09-hidden-genetic-delay-diabetes-diagnosis.html XX Novo Nordisk today announced the resubmission of its Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for Awiqli® (insulin icodec) injection, a once-weekly basal insulin treatment for adults living with type 2 diabetes. If approved, Awiqli® would become the first once-weekly basal insulin available in the United States, providing an alternative to daily basal insulin injections for adults living with type 2 diabetes.   The resubmission is based on results from the ONWARDS type 2 diabetes phase 3a program for once-weekly Awiqli® which is comprised of five randomized, active-controlled, treat-to-target clinical trials in approximately 4,000 adults with type 2 diabetes. The clinical program evaluated Awiqli® vs. daily basal insulin and the primary endpoint in these trials was change in A1C from baseline.1-5 Awiqli® is approved in the EU, along with 12 additional countries. In addition, regulatory filings have been completed in several other countries, with further regulatory decisions expected in 2025. XX Interesting news from Sequel Med Tech – they've signed an agreement with Arecor to pair the twiist pump with AT278 an ultra-concentrated (500U/mL), ultra-rapid insulin in development. They also have a deal with Medtronic to develop insulin for new pumps. This insulin isn't yet approved, it's 5 times stronger than standard fast acting  it's hoped that a clinical study will begin next year. Arecor says its insulin could potentially be the only option capable of enabling and catalyzing the next generation of longer-wear and miniaturized automated insulin delivery systems.   https://www.drugdeliverybusiness.com/sequel-arecor-develop-rapid-insulin-twiist/ XX Tandem Diabetes Care announes its t:slim X2™ insulin pump with Control-IQ+ automated insulin delivery (AID) technology is now cleared for use with Eli Lilly and Company's Lyumjev® (insulin lispro-aabc injection) ultra-rapid acting insulin in the United States (U.S.).   – The t:slim X2 insulin pump with Control-IQ+ technology is now cleared for use with Lyumjev for people with type 1 diabetes ages 2 and above and all adults with type 2 diabetes. The companies are continuing to work toward securing Lyumjev compatibility for the Tandem Mobi pump. https://hitconsultant.net/2025/09/29/tandem-diabetes-cares-tslim-x2-pump-cleared-for-use-with-lillys-ultra-rapid-lyumjev-insulin/ XX You can now place your order for the MiniMed™ 780G system with the Instinct sensor, made by Abbott. And if you are already a MiniMed 780G user, you can place an upgrade order today. ​This is a 15 day wear sensor, with no transmitter or overtape required. It looks the same at other Abbot sensors such as the Libre but is proprietary to Medtronic. Shipments are scheduled to start in November.   ​ https://www.drugdeliverybusiness.com/medtronic-launches-minimed-780g-instinct-abbott/   XX The global type 1 diabetes (T1D) burden continues to increase rapidly driven by rising cases, ageing populations, improved diagnosis and falling death rates. ,   The study estimates that T1D will affect 9.5 million people globally in 2025 (up by 13% since 2021), and this number is predicted to rise to 14.7 million in 2040. However, due to lack of diagnosis and challenges in collecting sufficient data, the actual number of individuals living with T1D is likely much higher, researchers say.   In fact, they estimate that there are an additional 4.1 million 'missing people' who would have been alive in 2025 if they hadn't died prematurely from poor T1D care, including an estimated 669,000 who were not diagnosed. This is particularly true in India, where an estimated 159,000 people thought to have died from missed diagnoses. The study predicts that 513,000 new cases of T1D will be diagnosed worldwide in 2025, of which 43% (222,000) will be people younger than 20 years old. Finland is projected to have the highest incidence of T1D in children aged 0-14 years in 2025 at around 64 cases per 100,000. The substantial increases in T1D forecasts between 2025 and 2040 underscore the urgent need for action. As co-author Renza Scibilia from Breakthrough T1D explains, "Early diagnosis, access to insulin and diabetes supplies, and proper healthcare can bring enormous benefits, with the potential to save millions of lives in the coming decades by ensuring universal access to insulin and improving the rate of diagnosis in all countries."   The authors note some important limitations to their estimates, including that while the analysis uses the best available data, predictions are constrained by the lack of accurate data in most countries-highlighting the urgent need for increased surveillance and research. They also note that data on misdiagnosis and adult populations remain limited, and the analysis assumes constant age-specific incidence and mortality over time. Furthermore, incidence data from the COVID-19 period were excluded from part of the modelling to avoid bias. Future updates are expected to improve as new data become available and applied. https://www.news-medical.net/news/20250919/New-study-warns-of-millions-of-undiagnosed-and-missing-people-with-type-1-diabetes.aspx XX A new study has found that semaglutide — the active ingredient found in some GLP-1 medications prescribed for diabetes and to aid weight loss — may help protect the eyes from diabetic retinopathy. Researchers estimate that as much as 40% of all people with diabetes also have diabetic retinopathy — a potentially blinding eye condition caused by blood vessel damage in the eye's retina. There is currently no cure for diabetic retinopathy. The condition is often managed through injections of anti-VEGF medications into the eye, surgery, and blood sugar monitoring and control. For this lab-based study, researchers used samples of human retinal endothelial cells that were treated with different concentrations of semaglutide. The cells were then placed in a solution with both a high glucose level and high level of oxidative stress — where there is an imbalance of antioxidants and free radicals — for 24 hours.   Past studies show that oxidative stress plays a role in the formation of diabetic retinopathy.   At the study's conclusion, researchers found that the retinal cells treated with semaglutide were twice as likely to survive than cells that were untreated. Additionally, the treated cells were found to have larger stores of energy.   Scientists also found that three markers of diabetic retinopathy were decreased in the semaglutide-treated retinal cells. First, the levels of apoptosis — a form of cell death — decreased from about 50% in untreated cells to about 10% in semaglutide-treated cells. The production of the free radical mitochondrial superoxide decreased from about 90% to about 10% in the treated retinal cells.   Researchers also found the amount of advanced glycation end-products — harmful compounds that can collect in people with diabetes and are known to cause oxidative stress — also decreased substantially.   Lastly, scientists reported that the genes involved in the production of antioxidants were more active in the semaglutide-treated cells when compared to untreated cells. Researchers believe this is a sign that semaglutide may help repair damage to the retinal cells.   “Our study did not find that these drugs harmed the retinal cells in any way — instead, it suggests that GLP1-receptor agonists protect against diabetic retinopathy, particularly in the early stages,” Ioanna Anastasiou, PhD, molecular biologist and postdoctoral researcher at the National and Kapodistrian University in Greece, and lead author of this study, said in a press release.   “Excitingly, these drugs may be able to repair damage that has already been done and so improve sight. Clinical trials are now needed to confirm these protective effects in patients and explore whether GLP-1 receptor agonists can slow, or even halt, the progression of this vision-robbing condition.” https://www.medicalnewstoday.com/articles/ozempic-semaglutide-may-help-protect-against-diabetes-related-blindness-retinopathy   XX Biolinq has received De Novo Classification from the U.S. Food and Drug Administration for its lead product, Biolinq Shine, a patch on the forearm that provides real-time glucose feedback through a primary color-coded LED display, visible with or without a phone. This one is tricky – it's called a needle free CGM but it also says it uses micro needles. By the way, De Novo isn't exactly the same as what we think of for FDA approval for medical devices. It's not as rigorous but it's a streamlined route for novel, low to moderate risk devices with no existing equivalent. We'll see how this one turns out. https://www.hmenews.com/article/biolinq-s-multi-function-biosensor-receives-fda-de-novo-classification

At long last, Jeff Alstott, the fairy godfather of DC AI policy, joins the show. He's the founding director for RAND's center for technology and security policy, TASP, worked at NSC, NSF and IARPA, and has a PhD in complex networks. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode I am joined by Dr Francisco José Luis, scholar of Indo-Iranian Studies and Comparative Religion trained at the Sorbonne, Paris and SOAS, London. Francisco recalls his upbringing and education in Luxembourg; details his rigorous academic training in classical languages such as Latin, Greek, and Sanskrit; and laments what he sees as the rise of idealogical indoctrination in modern education Francisco discusses his PhD in pre-reformist Sikhism, his years of field work living in the Punjab, and expresses his love of the German intellectual tradition. Francisco reveals the influence of Neoplatonism in Islamic theology and mysticism, describes his own turn to Shiʿi Islam, and explains why he believes that even today there is a living lineage of Neoplatonism that stretches directly back to Plotinus. … Video version: https://www.guruviking.com/podcast/ep327-neoplatonic-mystic-dr-francisco-jos-luis Also available on Youtube, iTunes, & Spotify – search ‘Guru Viking Podcast'. … Topics include: 00:00 - Intro 01:01 - Upbringing in Luxembourg 02:56 - Classical education 04:28 - Learning Latin, Greek, and Sanskrit 08:03 - Germanic intellectual tradition and WW2 12:37 - Advantages of an anti-American education 15:06 - Critical thinking and intellectual independence 17:04 - Boomer educators and idealogical indoctrination 20:59 - German literature 22:56 - Post WW2 culture shock and the boomer revolution 27:20 - Vatican II and loss of trust 30:35 - Filling education gaps 32:06 - A deeply pagan Catholic 35:21 - Meditation practice and interest in Neo-Vedanta 37:52 - Studying two masters degrees simultaneously at the Sorbonne 39:57 - Rigorous training in Sanskrit 43:56 - MA theses in French literature and pre-reform Sikhism 45:20 - PhD at SOAS in pre-reformist Sikh monastic orders 46:48 - Living among the Sikh community and learning Punjabi 49:54 - Young Sikh's interest in pre-reformist religion 50:54 - Death threats from Sikhs 53:00 - Changes in Sikhism 55:20 - Tradition religious music of Sikhism and other pre-reformist features 01:00:18 - Neo-traditionalist Sikh movements in the UK and India 01:03:59 - Falling in love with Shiʿi Islam 01:10:16 - Conversion to Islam? 01:11:45 - Shi'ism as a personal practice 01:13:23 - Cultural barriers against European converts 01:16:12 - Neo-Platonic Vajrayanism 01:17:43 - Mysticism perceived as a threat 01:21:48 - Neoplatonic influence on Islam 01:27:28 - Surprising Neo-Platonic features of Islamic mysticism 01:33:30 - Metempsychosis in Islam 01:37:16 - Francisco is a Neoplatonist 01:43:08 - Vajrayana and Shiʿi inner alchemy and dream yoga 01:50:43 - Islamic tummo … To find our more about Dr Francisco José Luis, visit: - https://www.instagram.com/hludvig_tradicionalista For more interviews, videos, and more visit: - https://www.guruviking.com Music ‘Deva Dasi' by Steve James

Ashish D. Aggarwal, PhD, is the cofounder and CEO of JubileeTV, a pioneering AgeTech company redefining how families support and stay connected with aging loved ones. Under his leadership, JubileeTV has transformed the television into a hub for remote caregiving, social connection, and independence, addressing a critical need as families navigate the challenges of aging at home. With more than 80 patents filed, the company has developed innovative solutions that simplify technology for older adults while empowering their families. Before founding JubileeTV, Aggarwal was at the forefront of consumer technology innovation. He launched Violet 3D, creating the world's first self-calibrating, wireless 3D surround sound system. He led engineering teams at Harman International, shaping cutting-edge audio and video technologies, and played a key role as an audio architect at PortalPlayer, contributing to the development of the first-generation iPod for Apple. Aggarwal holds a PhD in electrical engineering from the University of California, Santa Barbara, and continues to push the boundaries of how technology can enhance daily life for families and older adults.https://www.seniorcareauthority.com/resources/boomers-today/

Dana Love, founder of PoobahAI (exited 5 companies, PhD in economics), breaks down why Web3 lags mainstream adoption and how AI-built software can unlock the space: “the future of Web3 is coding without coders.” We cover: the zero→one grind, macro shifts (globalization → nationalization), inflation realities, and why blockchains need to drop the barrier to projects, devs, and users. Dana shares Poobah's approach—virtual co-founder, multi-chain no/low-code, pre-audited on-chain digital objects, and real showcases (NFT ticketing, RWA real estate, car auction). We also talk go-to-market (students & exec MBAs), chain partnerships, and their seed round.Timestamps[00:00] Dana's thesis: coding without coders is Web3's future[00:01] Background: exits, policy PhD, AI/ML → crypto since 2011[00:02] Patterns from 5+ exits: first $1 of revenue + investment; hearing “your baby is ugly”[00:04] Macro: globalization → nationalization; inflation dynamics & wages[00:07] Startup stages: 0→1 vs 1→10 vs 10→50—don't over-process the first customer[00:08] Why Web3 adoption lags: tooling, UX, paucity of devs/projects/users[00:10] Public vs private chains; why transparency is a feature for upstarts[00:11] Naming Poobah & the “many hats” founder[00:12] Poobah overview: virtual co-founder, on-chain generation, digital objects (pre-audited contracts)[00:15] Code quality: making no-code generate good code; best-practice RAG/context[00:17] Focus: Web3 first—massive untapped value[00:18] GTM: students, MBAs, exec MBAs → enterprise wedge[00:19] Case: Princeton CS student ships NFT ticketing as a vibe-coder[00:20] B2B: chain licenses to drop coding barrier to near-zero[00:22] The “hackathon circus” & why broadening the builder base matters[00:23] Non-dev creators as founders: fine-arts → sticky NFTs[00:24] The Shopify moment for Web3 (payments/regulatory context)[00:27] RWAs: real estate fractionalization; car auctions; built in weeks[00:30] Will AI replace devs? Senior vs junior leverage; law firm analogy[00:36] Market will rebalance skills & pay; seniors x AI = force multiplier[00:37] Roadmap (6–12 mo): low-code launch → no-code, multi-chain MCP, virtual co-founder[00:38] The ask: chain partnerships, seed syndication, universities & exec MBAsConnecthttps://poobah.ai/https://www.linkedin.com/company/poobahai/https://www.linkedin.com/in/danalove/https://x.com/DanaFLoveDisclaimerNothing mentioned in this podcast is investment advice and please do your own research. Finally, it would mean a lot if you can leave a review of this podcast on Apple Podcasts or Spotify and share this podcast with a friend.Be a guest on the podcast or contact us - https://www.web3pod.xyz/

In this episode of Most People Don't… But YOU Do!, Bart sits down with Dr. Fares Khalid Alaboud, Regional Director of Al Fares International Travel & Tourism. With a PhD in Artificial Intelligence and 15 years of experience in innovation and product leadership, Dr. Fares bridges travel, technology, and business strategy. From gratitude stones to groundbreaking AI applications in hospitality, this conversation blends personal storytelling with future-facing lessons on service, risk-taking, and curiosity.

Dr. Hassan Abbas is a water and hydrology expert with over 30 years of experience, holding a PhD in Hydrology and Water Resources from Michigan State University. He has worked on water resources across continents, focusing on Pakistan's Indus Basin, and is an advocate for people-centric water management. The Pakistan Experience is an independently produced podcast looking to tell stories about Pakistan through conversations. Please consider supporting us on Patreon:https://www.patreon.com/thepakistanexperienceTo support the channel:Jazzcash/Easypaisa - 0325 -2982912Patreon.com/thepakistanexperienceAnd Please stay in touch:https://twitter.com/ThePakistanExp1https://www.facebook.com/thepakistanexperiencehttps://instagram.com/thepakistanexpeperienceThe podcast is hosted by comedian and writer, Shehzad Ghias Shaikh. Shehzad is a Fulbright scholar with a Masters in Theatre from Brooklyn College. He is also one of the foremost Stand-up comedians in Pakistan and frequently writes for numerous publications. Instagram.com/shehzadghiasshaikhFacebook.com/Shehzadghias/Twitter.com/shehzad89Join this channel to get access to perks:https://www.youtube.com/channel/UC44l9XMwecN5nSgIF2Dvivg/joinChapters:0:00 Introduction2:00 Let the Rivers Flow7:50 Indus Water Treaty and Economic Imperialism13:40 Cold War Politics and the Indus Water Treaty 25:06 Kashmir, Headworks and the Radcliffe Award29:58 India and the Indus Water Treaty34:38 Can India control Pakistan's water and Narendra Modi43:50 Neelam Jhelum Project48:36 Solar Energy vs Hydroelectric Energy54:44 Kalabagh Dam and Water Scarcity 1:01:00 Predictions, Big Dams and Dam being removed1:12:00 Three Gorges Dam1:18:30 Pakistan doesn't need dams and Dr Hassan Abbas's solution 1:35:00 Monsoons and the Indus Delta1:38:20 Siltation1:39:19 Audience Questions

Welcome to Mastering Cyber with Host Alissa (Dr Jay) Abdullah, PhD, SVP & Deputy CSO at Mastercard, and former White House technology executive. Listen to this weekly one-minute podcast to help you maneuver cybersecurity industry tips, terms, and topics. Buckle up, your 60 seconds of cyber starts now! Sponsored by Mastercard: https://mastercard.us/en-us.html

Join George J. Chanos, Brian Vellmure, and Laura Hamill, PhD in this episode of DisrupTV as they explore the "Millennial Samurai" mindset, AI disruption, and the critical role of culture in driving organizational success. In this episode of DisrupTV, we explore the forces shaping our future — from personal empowerment and the “Millennial Samurai” mindset, to AI's disruptive impact on labor, energy, and business models, to the critical role of culture in organizations. Our guests share visionary perspectives on where humanity is headed, the choices leaders must make, and why culture remains a defining factor for success in the 21st century. DisrupTV is a weekly podcast hosted by R "Ray" Wang and Vala Afshar. The show airs live at 11 AM PT/ 2 PM ET every Friday. Each week, top leaders in tech, business, and innovation join to share their insights on the future of work, leadership, and digital transformation.

In this Huberman Lab Essentials episode, my guest is Dr. David Buss, PhD, a professor of psychology at the University of Texas at Austin and a pioneer in the field of evolutionary psychology. We explore the science behind human mate selection in both short- and long-term relationships. We discuss universal traits valued in long-term partners along with key differences between women and men in what they prioritize when selecting a mate. We also discuss the darker aspects of mating behavior, such as deception, the evolutionary function of jealousy and the motivations behind stalking. Read the episode show notes at hubermanlab.com. Thank you to our sponsors AGZ by AG1: https://drinkagz.com/huberman LMNT: https://drinklmnt.com/huberman Function: https://functionhealth.com/huberman Timestamps (0:00) David Buss (0:21) Mate Selection, Preferences & Competition (3:26) Desirable Qualities of Men & Women, Universal Traits for Long-Term Mates (4:38) Women's Preferences; Men's Preferences; Age Differences (8:58) Sponsor: LMNT (10:32) Mate Deception & Online Dating, Tool: Travel, Stress & Emotional Stability (13:41) Short- vs Long-Term Mates, Men vs Women Preferences (15:58) Sponsor: AGZ by AG1 (17:27) Jealousy, Mate Value Discrepancy, Vigilance to Violence (20:58) The Dark Triad, Sexual Harassment & Coercion (22:18) Stalking, Motivations & Outcomes (24:57) Sponsor: Function (26:38) Childhood Attachment Styles & Relationship Stability (27:43) Self-Assessment for Mate Value, Self-Esteem (31:20) Evolutionary Psychology & Neuroscience (32:05) David Buss' Books; Acknowledgements Disclaimer & Disclosures Learn more about your ad choices. Visit megaphone.fm/adchoices

The customer journey guides the lifetime value of our most important audiences, yet how do we ensure that we are planning, mapping, managing, and optimizing these journeys effectively? Agility requires a deep understanding of your customer's journey and the ability to adapt your strategies and tactics in real-time. It also demands a willingness to experiment, learn, and iterate quickly, embracing change as an opportunity rather than a threat. Today, we're going to talk about the exciting new Institute for Journey Management and how it's helping businesses unlock the power of customer-centricity in a complex and ever-changing world. To help me discuss this topic, I'd like to welcome, Mark Smith and Raymond Gerber from the Institute for Journey Management. About Mark Smith and Raymond Gerber Raymond GerberRaymond Gerber is Co-Founder of the Institute for Journey Management (I4JM) and Founder of JourneyCentric-CX, where he helps enterprises operationalize customer journeys to drive measurable value. With over 25 years of experience, including leadership roles at Qualtrics, Thunderhead (acquired by Medallia), Pegasystems, and Chordiant, Raymond has been at the forefront of journey orchestration, analytics, and AI-driven engagement. He holds 5 patents in journey analytics and customer experience innovation and has guided multiple SaaS organizations through successful acquisitions.Mark SmithMark Smith is Co-Founder of the Institute for Journey Management (I4JM) and Founder of Journey-Smiths, a boutique consultancy helping companies drive value from journey technology.  Mark has over 30 years of experience in customer analytics and engagement, including leadership roles at Kitewheel, CSG, Portrait Software and Quadstone - guiding a series of software start-ups to over $100M in exits.   He has steered customer analytic products to recognized market leadership positions since the late 1990s, and became a pioneer in the new domains of journey analytics and orchestration in 2013.   By training Mark is a statistician, with a PhD from the early days of AI and distributed computing.  However he fights against the statistician stereotype and has focused on customer and market alignment for products throughout his career.The Institute for Journey Management is a new industry association with a mission to unite journey management ecosystem members. It brings together business leaders, practitioners, implementers and vendors in a collaborative, non-profit initiative to develop shared knowledge of the business benefits possible from journey management.  Resources Institute for Journey Management: https://www.i4jm.org/ This episode is brought to you by Kinetic Data. Self-service without compromise. Build powerful self-service experiences across your entire organization without sacrificing speed, flexibility, security, or control. https://kineticdata.com/ Register now for Sitecore Symposium, November 3-5 in Orlando Florida. Use code SYM25-2Media10 to receive 10% off. Go here for more: https://symposium.sitecore.com/Don't Miss MAICON 2025, October 14-16 in Cleveland - the event bringing together the brights minds and leading voices in AI. Use Code AGILE150 for $150 off registration. Go here to register: https://bit.ly/agile150 Connect with Greg on LinkedIn: https://www.linkedin.com/in/gregkihlstromDon't miss a thing: get the latest episodes, sign up for our newsletter and more: https://www.theagilebrand.showCheck out The Agile Brand Guide website with articles, insights, and Martechipedia, the wiki for marketing technology: https://www.agilebrandguide.com The Agile Brand is produced by Missing Link—a Latina-owned strategy-driven, creatively fueled production co-op. From ideation to creation, they craft human connections through intelligent, engaging and informative content. https://www.missinglink.company

Sarah almost got swindled by her mechanic, but she's putting her foot down on the brakes. We learn what McDonald's claims Grimace is, and why Susie thinks they are lying and doing revisionist history for lolz. Sarah found out a fun fact about the David statue, but she is convinced it's a Mandela Effect situation. We learn why Disney theme parks are no longer trying to be affordable in any way, and they are fully embracing income inequality. Plus, Sarah teaches us roller coaster lingo. And there is a new predator to worry about, and evidently he's into sniffing butts.Brain Candy Podcast Presents: Susie & Sarah's SpOoOoOoOoktacular Spectacle, October 30, Oriental Theater, Denver, Colorado: Get your tickets! Brain Candy Podcast Website - https://thebraincandypodcast.com/Brain Candy Podcast Book Recommendations - https://thebraincandypodcast.com/books/Brain Candy Podcast Merchandise - https://thebraincandypodcast.com/candy-store/Brain Candy Podcast Candy Club - https://thebraincandypodcast.com/product/candy-club/Brain Candy Podcast Sponsor Codes - https://thebraincandypodcast.com/support-us/Brain Candy Podcast Social Media & Platforms:Brain Candy Podcast LIVE Interactive Trivia Nights - https://www.youtube.com/@BrainCandyPodcast/streamsBrain Candy Podcast Instagram: https://www.instagram.com/braincandypodcastHost Susie Meister Instagram: https://www.instagram.com/susiemeisterHost Sarah Rice Instagram: https://www.instagram.com/imsarahriceBrain Candy Podcast on X: https://www.x.com/braincandypodBrain Candy Podcast Patreon: https://www.patreon.com/braincandy (JOIN FREE - TONS OF REALITY TV CONTENT)Brain Candy Podcast Sponsors, partnerships, & Products that we love:Want to feel safer in online dating? Download Hily from the App Store or Google Play, or check out https://hily.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Angus Fletcher has a PhD in literature from Yale and teaches English at Ohio State. He's passionate about Shakespeare. He probably owns a tweed jacket. In other words, he's the last person you'd expect to receive the Army's fourth-highest civilian honor. But when he's not parsing King Lear or dissecting Hamlet, Angus is pioneering research into narrative cognition — our ability to think in stories — and how it can make us smarter. When the Army put his theories to the test, his methods reshaped how soldiers learn to think clearly under pressure and act decisively in volatile environments. Now, he has distilled this work into a new book called Primal Intelligence. Malcolm Gladwell says it's confirmation that Angus "has never had an uninteresting thought." We think you'll agree. — — — (04:21) What is Primal Intelligence? (8:24) Computers Think in Probabilities. Humans Think in Possibilities. (11:08) The Art of Intuition: Spotting Exceptions to Rules (29:59) Why Storytelling is the Essence of Human Intelligence (34:13) How to Plan (35:38) The Role of Emotion in Decision Making (45:27) How to Use Common Sense to ‘Tune Your Anxiety' (49:34) What Great Innovators Have in Common (51:25) The Best Way to Become a Better Communicator (54:22) Don't Freak Out About A.I. Do Freak Out the State of Your Intelligence. — — — Want to connect?

Listen to this episode commercial free at https://angryplanetpod.comPolitical assassins often have incoherent politics and Tyler Robinson is no different. The young man who killed Charlie Kirk inscribed the shell casings of his bullets with obscure memes that say less about what he believed and more about where he spent time online. Robinson isn't alone. Earlier this year the Annunciation Church shooter showed off a rifle inscribed with similar memes pulled from the internet. The Christchurch shooter in 2019 livestreamed their killing and left behind a meme laden manifesto.So what the hell is going on? On this episode of Angry Planet, Michael Senters—a PhD candidate at Virginia Tech—has some unsatisfying answers. Senters painstakingly walks us through each message on Robinson's bullets and explains the online spaces from whence they came.If you don't know a gropyer from a Helldiver or have never heard “OwO” said aloud, this episode is for you.It will not make you feel better.4,000 hours in seven gamesA painfully specific explanation of every shell casing meme“It can't be Helldivers”“This kid has probably fried his brain online.”Hearts of Iron IV's place in online fascist discourseSon, what's a groyper?There's no compelling evidence Robinson was a GroyperThe terrible embarrassment of explaining memes out loudThe 10 year old meme on the shell that killed KirkConstructing an ideology here is a Sisyphian taskBeing online is about irony and performanceHow a moment in time becomes a memetic hieroglyphAssassination as performanceGamergate as a “critical junction” in the Republican partyHow GG spread the irony-poisoned posting style like a virusFilming a TikTok video at an assassinationRe-evaluating our relationship to the internetA little bit about working in a bookstoreThe charging documents drop at the end of our conversationWhat the shell casings in the assassination of Charlie Kirk do – and don't – tell usYes, It's the Guns. It's Also the Phones.Read the Charges Against Tyler RobinsonExclusive: Leaked Messages from Charlie Kirk AssassinThe “Notices Bulge OwO” videoThe “Loss” comicSupport this show http://supporter.acast.com/warcollege. Hosted on Acast. See acast.com/privacy for more information.

MDs have main character energy, but don't ignore Physician Assistants. We talk a lot about medical students on this podcast, but at Iowa we also have a physician assistant program, one that's very well regarded, nationally. So to kick off national PA Week, we've got a bunch of PA students to talk about their profession. PA2s Emily Mazzeo and Abby Crow, and PA1s David Walker Hofbauer and Jake Groh talk about what it's like to study alongside MD students (something unique to Iowa), how they view their place in healthcare, how they knew they wanted to be a PA, and where they see their profession heading in the next few years. Hint: their profession is the 10th fastest-growing career in the US, with an enviable work-life balance, more mobility than MDs, and similar opportunities to specialize or go into primary care. BTW, you can find out more about the PA career, as well as the MD and biomedical science PhD programs, at our virtual conference next week! Episode credits: Producer: Emily Mazzeo and Abby Crow Co-hosts: Emily Mazzeo, Abby Crow, David Walker Hofbauer, Jake Groh We Want to Hear From You: YOUR VOICE MATTERS! We welcome your feedback, listener questions, and shower thoughts. Do you agree or disagree with something we said today? Did you hear something really helpful? Can we answer a question for you? Are we delivering a podcast you want to keep listening to? Let us know at https://theshortcoat.com/tellus and we'll put your message in a future episode. Or email theshortcoats@gmail.com. We need to know more about you! https://surveys.blubrry.com/theshortcoat (email a screenshot of the confirmation screen to

If you are listening to this prior to October 9, 2025, go to the 32BJ Changing the Playbook on Hospital Prices event, where Mark Cuban will be keynoting. Cora Opsahl will also be speaking, and I will be there listening. For a full transcript of this episode, click here. If you enjoy this podcast, be sure to subscribe to the free weekly newsletter to be a member of the Relentless Tribe. So, trust, simplicity, and a chicken. Yeah, this is where this whole conversation with Mark Cuban and Cora Opsahl winds up. And it is a barnstormer because you know what some really good advice is for anybody trying to do right by patients and taxpayers and plan sponsors? It will take trust. It will take making the complicated as simple as possible. And also if you could pay with a chicken, like in the good old days, that would be messy—I can say with confidence, having grown up in Pennsylvania Dutch country, where there are many, many chickens—but also being able to pay with a chicken could also indicate that healthcare prices are reasonably chicken proportionate and that the doctor-patient relationship is good enough to break bread (or have chicken). That last part is really important, and Cora Opsahl says this at one point in the episode that follows. It doesn't matter how wonderful the transparency or the financing. If the prices are insane and there's no more reasonably priced options in any given market, then yeah. Shane Cerone says in an upcoming show, he says, “We do not have a broken healthcare market. We do not have a healthcare market. There is no market.” Okay … so, you could call this conversation a continuation of the episode with Ann Kempski (EP444), entitled “Two State Healthcare Laws Often Don't Go as Planned.” But it's not just healthcare laws that often don't go as planned. It's some very foundational constructs that we have built the healthcare sector upon that may also not go as planned. The healthcare sector is like a game of pachinko. You chuck an input into the mix, and it will bounce all around into all the perverse incentives and human beings and the non-market that we have. And who the heck knows what is gonna pop out the other side? It's like game theory at its most unpredictable. So, in healthcare, there are many, many examples of when the solution to a problem arguably creates worse problems than the problems the solution was trying to solve for. But we—Mark Cuban, Cora Opsahl, and I—are gonna shake our fists at two such solutions today: high deductible health plans (or just high deductibles in general) and then self-insured employers trying to solve the complexity of the healthcare industry by hiring consultants and middlemen, middle people, and other vendors to navigate the pachinko parlor (that is, our $4.9 trillion healthcare sector) on their behalf. Now, I am not in any way saying the spirit of these two endeavors—high deductibles and hiring consultants and middlemen—weren't wholehearted. They seem just like many other well-intentioned solutions: very logical on their face. What I am saying is there are many ways in the real world for even the most, again, genuine endeavor to turn into a money grab for those so inclined. While at the same time I'm saying all this, I'm also very much saying that there are some amazing consultants and middle folks such as independent third-party administrators, otherwise known as TPAs, and PBMs (pharmacy benefit managers) who are transparent and hold themselves accountable to the fiduciary responsibilities that their clients are held to in real terms—not just in marketing speak with 40 pages of disclaimers following. There are great folks out there, many of whom listen to this podcast and are part of our tribe on the regular. And to you, I say thank you for being here, because it takes all the knowledge and more from every one of the guests featured in these past 487 Relentless Health Value episodes plus treating every day like a school day to make sure that we all are not getting shanked from behind by some innocent-looking contract term that turns out to be anything but. The conversation that follows starts out talking about high deductibles; naturally segues into how third-party intermediaries can actually exacerbate the issues here; then we get into transparency, financing, clinical organizations taking on risk, and the benefits and challenges of direct contracts; then Mark lays out a vision for the future. Okay … I wanna get to this conversation. If you are a new listener here—and you might be because … yeah, Mark Cuban—let me just inform you that this podcast is largely listened to by those who work in the healthcare industry. So, you are going to encounter acronyms. You will also encounter me referencing earlier episodes because surveys say listeners really appreciate these callbacks to go get additional information about any given topic. You can get what amounts to a personalized Master's of Healthcare Administration curriculum if you follow the episode threads long enough. And that was a direct quote from a listener. About the acronyms: They are holy terrors, and we in the healthcare industry are chock-full of them. See the list of acronyms that come up so that you can follow along at home if this is your first day at our rodeo. Also in the show notes is a transcript of this show, along with links to all of the mentioned episodes. Okay … here's my conversation with Mark Cuban, who is Mark Cuban and also CEO and founder of Mark Cuban Cost Plus Drugs. Also, we have Cora Opsahl, who is health fund director of the 32BJ Health Fund and an expert in many things healthcare. Also mentioned in this episode are Shane Cerone; Ann Kempski; Mark Cuban Cost Plus Drugs; 32BJ Health Fund; Preston Alexander; Stanley Schwartz, MD; Elizabeth Mitchell; Kimberly Carleson; Andreas Mang; Jonathan Baran; Claire Brockbank; Dave Chase; Cristin Dickerson, MD; Green Imaging; Kevin Lyons; and Vivian Ho, PhD.   You can learn more at markcubancompanies.com and costplusdrugs.com and follow Mark on LinkedIn, Bluesky, Threads, and X. You can follow Cora on LinkedIn.   Mark Cuban, a native of Pittsburgh, PA; a graduate of Indiana University; and now a Dallas, TX, resident, has always been an entrepreneur. From selling and trading baseball cards, selling garbage bags and magazines door-to-door, to starting a business buying and selling stamps at age 16, there have been few years in his life when he wasn't starting or running a business. He got a job at one of Dallas's first retail software stores, Your Business Software. He spent nine months doing everything from learning how to code, supporting and installing every type of business software, and of course, making sure the store opened on time. That went well until he made the executive decision to turn over the store opening duties to a peer so he could pick up a check for a sale. He was fired. Mark decided it was time to start on his own. The next day, MicroSolutions was founded. Over the next seven years, MicroSolutions became a national leader in Systems Integration and custom applications for local and wide area networks. Growing to 80 employees, never having a losing month of operations and nearly $36M in annualized sales, in 1990, MicroSolutions was sold to CompuServe. At that point Mark “retired” to investing in public and private companies. His knowledge of the networking industry led to success and brought returns of 80% and more each year. Mark purchased the Dallas Mavericks for $285M. The Mavs would have the second-best record in the NBA during his ownership tenure. Mark sold majority control of the Mavs in 2023 but continues to be actively involved with the team. He first appeared as a “Shark” on ABC's Emmy Award–winning hit business show Shark Tank in 2011 and quickly established himself as one of the most popular and tough Sharks, investing millions of dollars in hundreds of small businesses. He's been nominated nine times for an Emmy for Shark Tank. His last appearance on the program was during season 16 in May 2025. In 2019, Mark co-founded costplusdrugs.com. Its launch on January 19, 2022, with transparent pricing and a limited markup, has fundamentally changed the pricing of medications in the United States. Cora Opsahl is the director of the 32BJ Health Fund, a self-insured Taft-Hartley benefit fund that sets comprehensive design parameters to ensure the 200,000 members and families of SEIU 32BJ have easy and sustained access to affordable, high-quality healthcare. Cora has prioritized a data-driven approach, focusing on reducing trend, solving the affordability challenge on behalf of union members, and, most important, keeping members at the center of every decision. Under her leadership, the 32BJ Health Fund has saved more than $35 million annually—which it has reinvested in new and better benefits, including the first fertility benefit for members—by removing NewYork-Presbyterian hospitals and physicians from its network, transitioning to a new pharmacy vendor and pharmacy group purchasing coalition, and establishing an expanded Centers of Excellence program. In 2024, Cora conducted an innovative medical request for proposal, stipulating that all finalists have a signature-ready contract drafted by the 32BJ Health Fund prior to award. As a result, the Fund negotiated an agreement that brought unprecedented visibility and increased accountability to its benefit. In 2025, the Health Fund is focused on direct-contracting opportunities that allow it to carve out key benefits and ensure quality while managing spend. Cora is regarded as an expert in pharmacy benefit management and was recently appointed to the Board of Governors for the National Alliance for Healthcare Purchaser Coalitions and the Purchaser Advisory Council for the National Quality Forum and Joint Commission. She previously worked at Express Scripts, where she held a variety of roles, ranging from Medicare Part D to operations, strategy, and acquisitions. Cora earned an MBA from Saint Louis University.   06:25 What was the original rationale behind high deductibles? 07:38 How high deductibles are creating a class of functionally uninsured people. 09:29 EP482 with Preston Alexander. 10:20 “We're using health insurance as a proxy for healthcare.” —Mark 12:30 How providers are now in the debt collecting business rather than the healthcare business. 12:55 EP486 with Stan Schwartz, MD. 15:16 “We have a fundamental reasonability problem.” —Cora 16:07 EP425 with Marshall Allen. 18:25 Direct contracting versus self-funded employers. 19:27 EP436 with Elizabeth Mitchell. 19:30 EP480 with Kimberly Carleson. 19:33 EP372 with Cora Opsahl. 23:53 Why the current system doesn't allow the accountability that is needed. 24:39 EP452 with Cora Opsahl. 26:34 How direct contracting gives strength back to independent practices that high deductible plans take away. 27:46 Who pays, what's the price, and where does the power lie? 31:24 EP419 with Andreas Mang. 34:45 How it comes down to power and leverage when controlling healthcare costs. 38:13 EP483 (Part 1 and Part 2) with Jonathan Baran. 38:35 Why putting together a network and just buying healthcare—not discounts—is not as difficult as it seems. 40:10 Why we need to stop talking about disruption and start talking about change. 40:56 EP453 with Claire Brockbank. 41:02 EP484 with Dave Chase. 43:07 EP485 with Cristin Dickerson, MD. 44:32 EP487 (Part 1) with Kevin Lyons. 46:34 EP466 with Vivian Ho, PhD. 47:40 Why it's the incentives that are different between American hospitals and hospitals in a single-payer program. 50:25 The main takeaways from the conversation. 51:08 Why you can't fix the problems in healthcare without transparency.   You can learn more at markcubancompanies.com and costplusdrugs.com and follow Mark on LinkedIn, Bluesky, Threads, and X. You can follow Cora on LinkedIn.   @mcuban of @costplusdrugs and Cora Opsahl discuss trust and simplicity in #healthcare on our #healthcarepodcast. #podcast #financialhealth #patientoutcomes #primarycare #digitalhealth #healthcareleadership #healthcaretransformation #healthcareinnovation   Recent past interviews: Click a guest's name for their latest RHV episode! Kevin Lyons (Part 2), Kevin Lyons (Part 1), Dr Stan Schwartz (EP486), Dr Cristin Dickerson, Elizabeth Mitchell (Take Two: EP436), Dave Chase, Jonathan Baran (Part 2), Jonathan Baran (Part 1), Jonathan Baran (Bonus Episode), Dr Stan Schwartz (Summer Shorts), Preston Alexander

In this episode Rotem Petranker, PhD joins to discuss the current state of research on microdosing psilocybin. Dr. Petranker is the co-founder of the Psychedelic Studies Research Program at the University of Toronto and the Canadian Centre for Psychedelic Science. He recently ran the world's largest randomized controlled trial on the effectiveness of microdosing psilocybin on Major Depressive Disorder. In this conversation, Dr. Petranker shares insights from running the world's largest randomized controlled trial on psilocybin microdosing for major depressive disorder. He explains the origins of microdosing research, from early anecdotes and surveys to his team's carefully designed clinical study comparing psilocybin to placebo across different environments. While participants in both groups reported significant improvements, the findings point to the powerful role of expectancy and placebo effects, alongside nuanced signals of cognitive shifts on measures like dysfunctional attitudes. Dr. Petranker emphasizes the importance of rigorous methodology, open science, and transparency in psychedelic research, while also acknowledging the stories of participants whose lives were positively impacted by study participation itself.   In this episode, you'll hear: What early microdosing research suggested, and its limitations in anecdotal and survey-based designs Why psilocybin was chosen over LSD for the study design  What motivates people to try microdosing a psychedelic Key results from Dr. Petranker's study, including reports of both positive and adverse events How placebo effects—and simply being part of a trial—can powerfully shape outcomes Reflections on how psychedelics may work by increasing connectedness   Quotes: “There's no real rigorous definition [of microdosing]. People say, ‘oh, I'm just going to microdose some mushrooms,' and then they often take a random amount. I think what people mean is ‘I'm going to take an amount that will not knock me out, won't cause serious hallucinations,' but they still use an amount that they often feel. Now, this is in contrast to what people in the [academic] literature define it as, which is more like a sub-perceptual dose, a sub-hallucinogenic dose.” [2:17] “If you microdose and go to work, just to sit under the flickering lights for eight hours in your cubicle versus, say, if you're going to microdose and then go on a walk, or do art, or do as you wish because it's the weekend, you're going to have very different impacts on your anxiety.” [15:26] “[In our study] there were three other self-report measures of depression. There is only a significant difference on one of them, where people who were microdosing were doing better. And that was on the dysfunctional attitude scale, which measures more cognitive assumptions about life.” [26:2] “people who microdose—regardless of why they microdose—they more or less all said that they got to what they wanted through an increased sense of meaning.” [35:05]   Links: Psychedelic Studies Research Program at the University of Toronto Canadian Centre for Psychedelic Science website Canadian Centre for Psychedelic Science on X Canadian Centre for Psychedelic Science on Instagram Previous episode: Microdosing and the Placebo Effect with Balazs Szigeti, PhD Previous episode: James Fadiman answers your Microdosing Questions! Psychedelic Medicine Association Porangui  

Hospital-acquired pneumonia is among the most serious and costly hospital-acquired infections in the United States. Yet, as nurse, educator, and historian Dian Baker, PhD, APRN-BC, PNP, PHN explains, prevention can begin with something as simple as a toothbrush. In this SYN Insight, Baker shares how empowering patients, families, and nurses with knowledge and resources can dramatically reduce pneumonia rates, save lives, and cut costs. By bridging the long-standing divide between oral health and overall health, Baker shows how small, consistent actions can spark big change in complex healthcare systems.  To listen to this Insight clip's full episode visit SEE YOU NOW Podcast Episode 7: Brushing for Your Life at APPLE, SPOTIFY, YOUTUBE, or at your favorite streaming platform.   For more information on the podcast bundles, visit ANA's Innovation Website at https://www.nursingworld.org/practice-policy/innovation/education.    Have questions or feedback for the SEE YOU NOW team?  Future episode ideas? Contact us at hello@seeyounowpodcast.com.     

If you've been treating LinkedIn like just another social platform, you're missing out on one of the most powerful ways to grow your business. In this episode, I'm breaking down exactly how to use LinkedIn to attract high quality leads who are ready to connect, engage, and buy.Expand Your Brand on LinkedIn Masterclass: https://www.facebook.com/share/1BPu5g6QGV/The Goal Digger Certifications: https://bit.ly/GoalDiggerCertsJoin The Vault & Get Instant Access to 75+ Courses, Monthly Zoom Sessions, Curated Curriculum to fit your biz needs, New Courses add Each Month, and so much more!https://bit.ly/TheOfficialVault Grab your FREE copy of my book, ‘Boss It Up Babe!'https://bit.ly/BOSSItUpBabeBookHost Bio:Kimberly Olson is a self-made multi-millionaire and the creator of The Goal Digger Girl, where she serves female entrepreneurs by teaching them simple systems and online strategies in sales and marketing. Through the power of social media, they are equipped to explode their online presence and get real results in their business, genuinely and authentically. She has two PhDs in Natural Health and Holistic Nutrition, has recently been recognized as the #2 recruiter in her current network marketing company globally, is the author of four books including best-sellers, The Goal Digger and Balance is B.S., has a top 25 rated podcast in marketing and travels nationally public speaking. She is a mom of two and teaches others how to follow their dreams, crush their goals and create the life they've always wanted.Website: www.thegoaldiggergirl.comInstagram: www.instagram.com/thegoaldiggergirlFacebook: www.facebook.com/thegoaldiggergirlYoutube: www.youtube.com/c/thegoaldiggergirlGrab The Goal Digger Girl Journal: https://amzn.to/3BeCMMZCheck out my Facebook groups for those that want to build their business online through social media, in a genuine and authentic way:Goal Digging Boss Babes: http://bit.ly/GoalDiggingBossBabesFempreneurs:  https://bit.ly/FempreneursCashFlowQueensLeave a review here: Write a review for The Goal Digger Girl Podcast.Subscribing to The Podcast:If you would like to get updates of new episodes, you can give me a follow on your favorite podcast app.

Not all meditation experiences are peaceful — and that's something we need to talk about. In this conversation, meditation teacher Meryl Arnett sits down with mindfulness trainer and trauma expert David Treleaven, PhD, author of The Trauma Sensitive Mindfulness Workbook, to explore how trauma impacts meditation and vice versa.If you've ever felt overwhelmed, dysregulated, or triggered during meditation practice, this episode will help you understand why — and give you practical tools to work with these challenging experiences.What To ExpectWhy meditation can trigger trauma responses and what to do about itThe spectrum of trauma: understanding the difference between stress, traumatic stress, and PTSDThe Window of Tolerance: a powerful framework for knowing when to lean into meditation and when to back offBeing with vs. working with: two essential approaches to meditation practicePractical regulation tools beyond traditional seated meditationPerfect ForMeditation practitioners experiencing difficulty or overwhelm in practiceYoga and meditation teachers wanting to develop trauma-informed teaching skillsMental health professionals integrating mindfulness into their workAnyone with a trauma history exploring meditationParents helping children develop emotional regulation skillsAnyone interested in understanding the intersection of meditation and mental healthFeatured GuestDavid Treleaven, PhD is a writer, educator, and trauma professional specializing in trauma-sensitive mindfulness. His work helps meditation teachers and practitioners understand how to work skillfully with trauma in contemplative practice. He's trained thousands of meditation teachers worldwide and his resources include The Trauma Sensitive Mindfulness Workbook and various online trainings.Find David at: davidtreleaven.comResources MentionedThe Trauma Sensitive Mindfulness Workbook by David TreleavenWidening the Window by Elizabeth StanleyTeachers referenced: Tara Brach, Jack Kornfield, Rick HansonFree trauma-informed meditation webinar available at davidtreleaven.comJoin the ConversationHave you experienced challenges in your meditation practice? What tools help you regulate when practice becomes overwhelming? Share your experiences on social media using #meditatewithmerylDisclaimer: This podcast is for educational and informational purposes only and is not a substitute for professional mental health treatment. If you're experiencing trauma symptoms or mental health concerns, please consult with a qualified mental health professional.Learn more and sign up for Nature's Reflection: A Meditation and Forest Bathing Retreat happening October 23 - 26 here: https://www.hambidge.org/workshop-schedule/natures-reflection-a-meditation-and-forest-bathing-retreatSign up for my newsletter at http://eepurl.com/jjPrV2 to receive free mini meditations and soundscapes each week, along with creative musings and more.New episodes every Monday (just the meditation) and Thursday (a full meditation class).Learn more or contact me at https://www.merylarnett.com/. Thank you to Brianna Nielsen for production and editing support. Find her at:https://www.instagram.com/itsbriannanielsenThis podcast explores meditation, mental health and the power of connection, offering guidance for caregivers, healers, and therapists facing compassion fatigue, burnout, and other mental health struggles through self-care, self-compassion, and resilience. With a focus on anxiety, depression, and overwhelm, each episode provides tools like meditation, mindfulness, breathwork, and grounding to cultivate clarity and reduce stress. Listeners can also experience nature-inspired guided meditations, designed to bring peace and balance in times of distress.

“Our history is not a history of divide. Our history is a history of coming together in greater and greater numbers.” - john a. powellIn this special bonus episode, Thomas sits down with john a. powell, law professor and Director of the Othering and Belonging Institute, to investigate the root causes and social function of “othering.”Humans are wired for connection, and according to john, othering is actually an unfortunate byproduct of our desire to belong and survive within a specific group.He and Thomas explore how storytelling has shaped the trajectory of human evolution, and how we can embrace our inherent interconnectedness to write more inclusive and peaceful stories for our shared future.If you'd like to hear the full conversation between john and Thomas, it's one of over 30 talks included in the upcoming Collective Trauma Summit 2025. Click on the link below to register for this free online event.✨ Click here to watch the video version of this episode on YouTube:

Welcome to Dr. M's Women & Children First Podcast, where we engage with pioneering voices at the intersection of science, healthcare, and the well-being of families. Today, I'm honored to introduce Dr. William Parker, PhD. Dr. Parker is perhaps best known for discovering the function of the human appendix, but his contributions to science extend far beyond that single discovery. He studied biology and chemistry as an undergraduate before earning his PhD in Chemistry from the University of Nebraska–Lincoln in 1992. Since the 1980s, he has conducted innovative research, publishing more than 150 peer-reviewed articles that span immune function, microbiome science, and human health. Dr. Parker was the first to compare immune systems in wild animals with those of their laboratory counterparts, and among the first to conclude that changes in the human “biota”, the symbiotic organisms living within us, brought on by modern society can contribute to depression and anxiety. After nearly three decades at Duke University, where he served as associate professor and research leader, he founded WPLab, Inc., a nonprofit dedicated to understanding and educating about the causes of chronic inflammatory diseases in high-income societies. Currently a visiting scholar at the University of North Carolina, Dr. Parker collaborates widely with colleagues from Duke University, University of Montreal, Czech Academy of Sciences, University of Groningen, University of Colorado Boulder, and scientists across the pharmaceutical industry. In recent years, he has turned his attention to a provocative and urgent question: the potential links between early acetaminophen exposure and autism spectrum outcomes. His current work combines mechanistic and epidemiologic approaches to explore how acetaminophen's effects on human physiology at critical stages of development might influence neurodevelopment. In our conversation, we'll explore: The evidence and hypotheses behind acetaminophen's potential role in autism risk What families and clinicians should know: what's plausible, what remains speculative, and where research is heading next I'm thrilled to share this episode with Dr. Parker, whose intellectual curiosity, scientific rigor, and courage to ask difficult questions embody the spirit of this show. Dr. M

First-Ever Substack Livestream – Exposing AI Slavery, Surveillance, and Technocratic Control In this groundbreaking first-ever Substack livestream, Courtenay Turner sits down with technocracy expert Patrick Wood (@StopTechnocracy) to hype the must-attend Omniwar: Academia Weighs In on the Digital Attack on Humanity symposium. Tune in as they break down the urgent threats of biodigital convergence, AI as a "machine god," and global surveillance turning us into technoplastic beings. Catch a sneak peek of the lineup for Saturday, October 4, 2025 (9 AM ET / 6 AM PT): ➤ Patrick Wood: "Building Empire on the Backs of Digital Slaves" – The OG on AI, blockchain, and technocratic domination. ➤ David A. Hughes, PhD (UK): "Digital Technologies as Weapons" – Smartphones as gateways to cognitive warfare. ➤ Jacob Nordangård, PhD (Sweden): "Externalizing the Agentic AI State" – Techno-spiritual enslavement and the "world organism." ➤ Daniel Broudy, PhD (Japan): "Born Again: The Convergence of Man and Machine in the Spirit of AI-god" – Transhumanism's invasion. This international powerhouse of PhDs (plus Patrick's 45 years of hard-knocks wisdom) delivers 5+ hours of eye-opening talks. It's an attack on humanity—not just one nation—and we need to push back NOW. RSVP for the free livestream (YouTube, Rumble, technocracy.news, CHD.tv, and more global servers to dodge censorship): https://www.technocracy.news/digital/ Share this far and wide—blast it to friends, family, and the curious (and even the skeptics). Knowledge is our weapon against the digital empire. #Omniwar #Technocracy #AISlavery #CognitiveLiberty #FreedomFighters Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, Curtis May sits down with Dr. Laquore J. Meadows, wealth strategist, educator, and CEO of Invest2Give and founder of Stocks & Sorors. Rising from poverty to earning her Ph.D., Dr. Meadows built a business dedicated to helping professionals and entrepreneurs take control of their financial futures through stock and options trading. We dive deep into her signature framework, the Wealth HOUZ, and her mission to show that your financial freedom should never hinge on politics, headlines, or fear of the market.   Highlights What You'll Learn:   -Why elections and headlines don't control your financial destiny -How the Wealth HOUZ helps you move from renting your financial future to owning it -A 3-step framework to turn market uncertainty into opportunity Dr. Meadows's journey from poverty to PhD  and the lessons she brings to wealth creation   Key Takeaway: Financial empowerment begins with mindset and structure, not circumstances. You can build wealth regardless of who's in office or what the market is doing.    Links and Resources from this Episode https://www.practicalwealthadvisors.com https://www.practicalwealthsolutions.net/ Email Curtis for a free report - curtmay@gmail.com  Call his office - 610-622-3121 ERC Tax Credit - https://ercspecialists.com?fpr=curtis75 Schedule a call with Curtis: https://aptwithcurtis.as.me/Strategysession CashFlow Mapping: https://practicalwealth.cashflowmapping.com/lp/PWbudgetsstink  Take the Next Step with Curtis May: Business Owners: Assess Your Challenges with Cash Flow → https://curtis-73no5r8j.scoreapp.com  Private Banking Readiness Assessment → https://curtis-qljorw8q.scoreapp.com  How Ready Are You to Be Your Own Bank? → https://link.agent-crm.com/widget/quiz/XJwH7kM0wWxYB1KICcOW  Connect with Dr. Laquore Meadows laquoremeadows@gmail.com  Instagram: @invest2give  LinkedIn: Dr. Laquore J. Meadows Website: invest2give.com  Special Listener Gift Schedule a 15-Minute Call with Curtis: https://aptwithcurtis.as.me/Strategysession   Review, Subscribe and Share If you like what you hear please leave a review by clicking here   Make sure you're subscribed to the podcast so you get the latest episodes. Click here to subscribe with Apple Podcasts  Click here to subscribe with Spotify Click here to subscribe with RSS

Dr Susan Kleiner is a PhD of Nutrition and Human Performance and a Registered Dietician who's worked with the highest level athletes in sports. Susan guests in this masterclass on performance nutrition to share her expertise on:-Fuelling for athletic performance -Do female athletes face more pressure than men to appear lean-Tactics for short term leanness while not losing training effectiveness-Long term tactics to manage performance and aesthetic goals-The criticism female athletes like Serena Williams have traditionally faced, plus some nuanced thoughts on Serena's current use of GLP-1 agonist medications-Fasted cardio-Leanness and injury risk-Creating client autonomy for adherence-Signs you're potentially under-fuelling-Common micronutrient deficiencies in active people-And much more01:06 Pressure on Female Athletes04:21 Media Influence on Athlete Image08:27 Nutrition and Performance in Female Athletes12:57 Sponsorship and Media Demands15:53 GLP-1 Agonists and Athlete Health22:04 Fueling Strategies for Athletes32:42 Seasonal Nutrition Management38:45 Injury Risks and Body Composition40:02 The Ice Cream Boy: A Case Study45:42 Identifying Under-Fueling in Athletes52:52 The Female Athlete Triad01:04:23 Micronutrient Deficiencies in Athletes01:09:01 The Role of Dietitians in Sports NutritionI've been putting a lot of time and effort into making these new episodes valuable for you. You can help me get these great guests and their knowledge in front of more people by:-Subscribing and checking out more episodes-Sharing on your social media (please tag me - I promise I'll respond)-Sharing with the friend you think of who needs this episodeFollow Andrew Coates:Instagram:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@andrewcoatesfitness⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Join My Email List:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.andrewcoatesfitness.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Get the RP App at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.rpstrength.com/coates⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ - use the code COATESRPUse Code ANDREWCOATESFITNESS to save 10% off at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://justbitememeals.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Use MacrosFirst for tracking nutrition ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.macrosfirst.com/⁠⁠Go to www.knkg.com/Andrew59676 for 15% off your KNKG bag.

Dr. Brad Schoenfeld, PhD is one of the world's leading researchers on muscle hypertrophy (muscle growth). He is a Professor of Exercise Science at Lehman College in New York, where he directs the Human Performance Laboratory. Over his career, he has published more than 300 peer-reviewed articles, book chapters, and textbooks on resistance training, body composition, and nutrition.He is the author of Science and Development of Muscle Hypertrophy and The Max Muscle Plan, and has received prestigious honors such as the NSCA Young Investigator of the Year and the Dwight D. Eisenhower Fitness Award. Beyond academia, he has been a personal trainer and natural bodybuilding competitor, which allows him to uniquely bridge cutting-edge science with practical application.Here's what he knows: the fitness industry has been selling you the wrong story. Not maliciously, but confidently. And most people are paying the price without even realizing it.In this episode, Brad reveals why so many people are working harder than they need to while missing the basics that matter most. We discuss the beliefs keeping women from reaching their potential, the risks that sneak up when you avoid certain types of training, and what actually determines whether you stay strong and independent decades from now. He also tackles the myths around supplements, workout structure, and whether you're doing enough or too much.If you're ready to stop spinning your wheels and start training smarter, this conversation will show you exactly where to begin.Chapters:00:00 - Meet Dr. Schoenfeld & why strength training is vital for health07:00 - Metabolic health, bone density & preventing osteoporosis15:00 - Training for strength, hypertrophy & power (and busting myths)25:00 - Practical routines: how much volume, soreness, and recovery time34:00 - Glute growth, exercise variety & women's training differences45:00 - Protein, fueling & the truth about creatineDr. Schoenfeld's Social + WebsiteWebsite: https://www.lookgreatnaked.com/Instagram: https://www.instagram.com/bradschoenfeldphd/Kayla's Social + WebsiteInstagram: https://www.instagram.com/kaylabarnes/TikTok: https://www.tiktok.com/@femalelongevityTwitter: https://x.com/femalelongevityWebsite: https://www.kaylabarnes.comFollow Her Female Protocol: https://www.protocol.kaylabarnes.com

Interviewee: Bassel Shanab, BS is a fourth-year medical student at the Yale School of Medicine.  Interviewer:  Lisa Meeks, PhD, MA, Guest Editor, Academic Medicine Supplement on Disability Inclusion in UME. Description: This episode of Stories Behind the Science sits down with Bassel Shanab (Yale School of Medicine), co-first author of “The Intersection of Disability, Race, Ethnicity, and Financial Background on Food Insecurity Among Medical Students,” part of the Academic Medicine supplement on Disability Inclusion in UME. We move beyond prevalence rates to the lived realities behind them—and why hunger so often hides in plain sight in elite training environments. Bassel shares the personal experiences that shaped his questions, the multi-institutional data that sharpened the answers, and the practical moves any school can make now: screen routinely, get cost-of-living estimates right, normalize help-seeking, and invest in evidence-based campus supports. Along the way, we talk flourishing (not just “fixing”), student-led research networks, and why transparency beats stigma every time. Whether you're a dean, DRP, faculty member, or student, this conversation offers a humane roadmap from surviving to thriving. Links to the open-access article, and related tools are in the show notes. Transcript:  https://docs.google.com/document/d/184LJqvcAgHGmpHyOcaxOxRw4yetR7qrGPPin0HDX7i4/edit?usp=sharing   Bios:   Bassel Shanab, BS is a fourth-year medical student at the Yale School of Medicine. He holds a Bachelor of Arts in Biological Sciences and Global Health Studies from Northwestern University, graduating with distinction. His academic interests include medical education, cardiovascular health, social determinants of health, and health policy. Key Words:   Food insecurity Medical students Disability Race and ethnicity Underrepresented in medicine (URiM) Low-income background Intersectionality Student well-being Academic performance   Resources:  Article from Today's Talk The Intersection of Disability, Race, Ethnicity, and Financial Background on Food Insecurity Among Medical Students   Nguyen, Mytien MS; Shanab, Bassel M.; Khosla, Pavan; Boatright, Dowin MD, MBA, MHS; Chaudhry, Sarwat I. MD; Brandt, Eric J. MD, MHS; Hammad, Nour M. MS; Grob, Karri L. EdD, MA; Brinker, Morgan; Cannon, Caden; Cermack, Katherine; Fathali, Maha; Kincaid, John W.R. MS, MPhil; Ma, Yuxing Emily; Ohno, Yuu MS; Pradeep, Aishwarya; Quintero, Anitza MBA; Raja, Neelufar; Rooney, Brendan L.; Stogniy, Sasha; Smith, Kiara K.; Sun, George; Sunkara, Jahnavi; Tang, Belinda; Rubick, Gabriella VanAken MD; Wang, JiCi MD; Bhagwagar, Sanaea Z.; Luzum, Nathan; Liu, Frank MS; Francis, John S. MD, PhD; Meeks, Lisa M. PhD, MA; Leung, Cindy W. PhD. The Intersection of Disability, Race, Ethnicity, and Financial Background on Food Insecurity Among Medical Students. Academic Medicine 100(10S):p S113-S118, October 2025. | DOI: 10.1097/ACM.0000000000006156   https://journals.lww.com/academicmedicine/fulltext/2025/10001/the_intersection_of_disability,_race,_ethnicity,.12.aspx The Docs With Disabilities Podcast https://www.docswithdisabilities.org/docswithpodcast

Send us a textIf you've ever felt forced to choose between a telescope and a tarot deck, this conversation will make you breathe easier. We chatted with Rosa Hope—a practicing PhD astrophysicist and transpersonal hypnotist—to trace the surprising places where hard science and deep spirit not only coexist, but actually help each other do their best work. Rosa unpacks materialism in plain language, shows how quantum-scale weirdness challenges “solid” reality, and explains why science answers "how" while spirituality answers "why."Rosa shares the raw story of losing a roommate, developing severe PTSD, and finding unexpected relief in a single 90-minute hypnosis session that unraveled a core pattern of guilt. She offers a pragmatic bridge for skeptics: you don't have to believe in angels or past lives; treat it as a guided imaginative exercise and judge by results—less pain, more agency, better relationships. Rosa also challenges default cultural lenses, naming the limits of Jungian dream symbols and uplifting learning within living traditions. The through line is generous and clear: meet people where they are, let practice lead belief, and use these tools in service of healing.If you're curious about hypnosis, integration, and the space between the measurable and the meaningful, this is your map. To learn more or to work with Rosa:Visit: www.rosa-hope.comClairvoyaging is now a fiscally sponsored project of Fractured Atlas, a 501(c)(3) charity, so any donations are now tax deductible. If you'd like to support our projects that aim to foster understanding for diverse spiritual belief systems, visit www.clairvoyaging.com/support. Support the show-- DONATE to the Clairvoyaging Documentary (it's tax-deductible!)-- SUBSCRIBE in your preferred podcast app! -- Follow @clairvoyagingpodcast on Instagram.-- Send us an email: clairvoyagingpodcast@gmail.com-- Become a Clairvoyager on Patreon and get access to exclusive extras!

Molecular-medicine expert Dr. Nathan Bryan explains how nitric oxide (NO) protects the endothelium, drives vasodilation, and influences energy, immunity, hormones, and longevity. He links stubborn hypertension and poor exercise tolerance to the microbiome–NO axis and outlines common NO killers—antiseptic mouthwashes and fluoride overuse, chronic PPIs, ultra-processed diets, and inactivity. We cover practical restores (movement, nutrient-dense food, targeted micronutrients, careful PPI weaning, ditching antiseptic rinses) and preview clinical work on NO-releasing lozenges for ischemic heart disease, approaches to improve cerebral blood flow and insulin signaling in cognitive decline, and topical NO for chronic wounds. Bryan also touches on food quality (glyphosate, soil health), hormone synergy with NO, and NO-based skincare that supports perfusion and collagen. Bottom line: rebuild NO, and the body's own repair systems can finally do their job.(Educational only; not personal medical advice.)Guest BioNathan S. Bryan, PhD is a molecular medicine researcher and leading authority on nitric oxide (NO) biochemistry. Over two decades, he has mapped how the body generates and uses NO—and what happens when it doesn't—publishing widely, authoring multiple books, and translating discoveries into products and late-stage drug trials. His work spans cardiovascular health, metabolism, neurocognition, wound healing, and skin biology, with a focus on restoring NO as a foundation for repair. Dr. Bryan speaks globally on NO and leads development of NO-based therapeutics targeting ischemic heart disease, Alzheimer's disease, and non-healing ulcers. GET SOCIAL WITH US!

In this milestone episode of the Fit4Privacy podcast, host Punit Bhatia is joined by three distinguished privacy experts — Dr. Kerry Miller (AI Governance Expert, U.S.), Heidi Waem (Partner, DLA Piper, Brussels), and Dr. Valerie Lyons (COO, BH Consulting; Academic & Author) — to reflect on 7 years of GDPR and explore what lies ahead. Whether you're a privacy professional, business leader, or just curious about how data protection shapes our digital lives, this conversation offers both a critical reflection on GDPR's first seven years and foresight into its future role in AI and trust. KEY CONVERSION 00:03:25 Panelist Introductions and Initial Thoughts on GDPR 00:09:06 Significant challenge that remains in up to 7-9 years of GDPR 00:18:10 Has there been a fair amount of reporting on compliance failures over the years? 00:21:11 EU Compliance Gaps and How Companies Can Avoid Them  00:29:56 Has the GDPR has been successful in balancing the power equilibrium of organization and data subjects?  00:35:35 Role of trust after 7 years of GDPR  00:41:39 From GDPR compliance in AI World, what can be done additionally? ABOUT GUEST Heidi Waem is the head of the data protection practice at DLA Piper Belgium and specialized in data protection and privacy. She assists clients with all aspects of EU Regulatory Data Protection compliance including the ‘structuring' of data processing and sharing activities to achieve an optimal use of data, advising on data transfers and the processing of personal data by means of new technologies (AI, facial recognition,…).Dr. Cari Miller is the Principal and Lead Researcher for the Center for Inclusive Change. She is a subject matter expert in AI risk management and governance practices, an experienced corporate strategist, and a certified change manager. Dr. Miller creates and delivers AI literacy training, AI procurement guidance, AI policy coaching, and AI audit and assessment advisory services.Dr. Valerie Lyons is a globally recognized authority in privacy, cybersecurity, data protection, and AI governance. Holding a PhD in Information Privacy along with CDPSE, CISSP, and CIPP/E certifications, she serves as a trusted strategic advisor to regulatory bodies and organizations across both public and private sectors. Valerie has played an influential role in shaping EU-wide data protection frameworks and enforcement strategies, and is an active member of the European Data Protection Board's pool of experts, as well as other global cyber and data protection bodies. ABOUT HOSTPunit Bhatia is one of the leading privacy experts who works independently and has worked with professionals in over 30 countries. Punit works with business and privacy leaders to create an organization culture with high privacy awareness and compliance as a business priority. Selectively, Punit is open to mentor and coach professionals. Punit is the author of books “Be Ready for GDPR' which was rated as the best GDPR Book, “AI & Privacy – How to Find Balance”, “Intro To GDPR”, and “Be an Effective DPO”. Punit is a global speaker who has spoken at over 30 global events. Punit is the creator and host of the FIT4PRIVACY Podcast. This podcast has been featured amongst top GDPR and privacy podcasts.As a person, Punit is an avid thinker and believes in thinking, believing, and acting in line with one's value to have joy in life. He has developed the philosophy named ‘ABC for joy of life' which passionately shares. Punit is based out of Belgium, the heart of Europe. RESOURCESWebsites ⁠⁠www.fit4privacy.com⁠⁠,⁠⁠www.punitbhatia.com⁠⁠, ⁠⁠https://www.linkedin.com/in/heidiwaem/⁠⁠, ⁠⁠https://www.linkedin.com/in/cari-miller/⁠⁠, ⁠⁠https://www.linkedin.com/in/valerielyons-privsec/⁠⁠ Podcast⁠⁠ ⁠⁠⁠⁠https://www.fit4privacy.com/podcast⁠⁠ Blog ⁠⁠https://www.fit4privacy.com/blog⁠⁠ YouTube ⁠⁠http://youtube.com/fit4privacy⁠⁠

Sholto Douglas, a top AI researcher at Anthropic, discusses the breakthroughs behind Claude Sonnet 4.5—the world's leading coding model—and why we might be just 2-3 years from AI matching human-level performance on most computer-facing tasks.You'll discover why RL on language models suddenly started working in 2024, how agents maintain coherency across 30-hour coding sessions through self-correction and memory systems, and why the "bitter lesson" of scale keeps proving clever priors wrong.Sholto shares his path from top-50 world fencer to Google's Gemini team to Anthropic, explaining why great blog posts sometimes matter more than PhDs in AI research. He discusses the culture at big AI labs and why Anthropic is laser-focused on coding (it's the fastest path to both economic impact and AI-assisted AI research). Sholto also discusses how the training pipeline is still "held together by duct tape" with massive room to improve, and why every benchmark created shows continuous rapid progress with no plateau in sight.Bold predictions: individuals will soon manage teams of AI agents working 24/7, robotics is about to experience coding-level breakthroughs, and policymakers should urgently track AI progress on real economic tasks. A clear-eyed look at where AI stands today and where it's headed in the next few years.AnthropicWebsite - https://www.anthropic.comTwitter - https://x.com/AnthropicAISholto DouglasLinkedIn - https://www.linkedin.com/in/sholtoTwitter - https://x.com/_sholtodouglasFIRSTMARKWebsite - https://firstmark.comTwitter - https://twitter.com/FirstMarkCapMatt Turck (Managing Director)LinkedIn - https://www.linkedin.com/in/turck/Twitter - https://twitter.com/mattturck(00:00) Intro(01:09) The Rapid Pace of AI Releases at Anthropic(02:49) Understanding Opus, Sonnet, and Haiku Model Tiers(04:14) From Australian Fencer to AI Researcher(12:01) The YouTube Effect: Mastery Through Observation(16:16) Breaking Into AI Research Without Traditional Signals(18:29) Google, Gemini, and Building Inference Stacks(23:05) Why Anthropic? Culture and Mission Differences(25:08) What Is "Taste" in AI Research?(31:46) Sonnet 4.5: Best Coding Model in the World(36:40) From 7 Hours to 30 Hours: The Long-Context Breakthrough(38:41) How AI Agents Self-Correct and Maintain Coherency(43:13) The Role of Memory in Extended Coding Sessions(46:28) Breakthroughs Behind the Performance Jump(47:42) Pre-Training vs. RL: Textbooks vs. Worked Problems(52:11) Test-Time Compute: The New Scaling Axis(55:55) Why RL Finally Started Working on LLMs in 2024(59:38) Defining AGI: Better Than Humans at Computer Tasks(01:02:05) Are We Hitting a Plateau? Evidence Says No(01:03:41) The GDP Eval: Measuring AI Across Economic Sectors(01:05:47) Preparing for 10-100x Individual Leverage & Robotics

Today's guest, world-renowned primatologist and environmentalist Dr. Jane Goodall discusses our relationship with the animal kingdom. We are all connected. We are harming the planet, and therefore if affects the animals. Dr. Goodall discusses her extensive study of primatology and specifically her work with chimpanzees. In her vast travels, she talks about how there were more than 1 million chimpanzees, and now we have less than 200,000, some of which have little chance of survival as they are spread far apart.  She is also the founder of “Roots and Shoots,” a non-profit organization which encourages children in more than 70 countries to study wildlife. Roots and Shoots focuses on teaching young people the importance of taking care of our planet. She invited students from countries who were at war to speak at the UN in honor of International Peace Day. Dr. Goodall is a UN Messenger of Peace. In July 1960, at the age of 26, Dr. Goodall traveled from England to what is today Tanzania and bravely entered the little-known world of wild chimpanzees. Her unyielding patience and characteristic optimism won the trust of these initially shy creatures. She managed to open a window into their sometimes strange and often familiar-seeming lives.  Dr. Goodall later earned a PhD in ethology, the study of animal behavior, from the University of Cambridge, with her thesis detailing the first five years of study at the Gombe reserve. In 1977, she founded the Jane Goodall Institute with Genevieve di San Faustino. Headquartered in Washington, D.C., with offices in 25 cities around the world, the organization aims to improve the treatment and understanding of primates through public education and legal representation. Today, her work revolves around inspiring action on behalf of endangered species, particularly chimpanzees, and encouraging people to do their part to make the world a better place for people, animals, and the environment we all share. Info: www.janegoodall.org and www.rootsandshoots.org This interview was originally broadcast in late Sept 2006 and talks about a worldwide event happening to raise awareness of peace and the environment. We air this today in honor of Dr. Jane Goodall, who passed away Oct 1.

The Advanced Air Mobility (AAM) industry is demanding Aerospace parts at Automotive rates.  Learn from aerospace and automotive industry leaders who will share the unique manufacturing, quality and inspection requirements for aerospace composites and current challenges to high-rate manufacturing.  Insights from manufacturing experts with a command of high volume production will also be discussed.  Don't miss this opportunity to gain knowledge from aerospace composite manufacturing experts from the Society for the Advancement of Material and Process Engineering (SAMPE) and the Society of Manufacturing Engineers (SME) who will elaborate on the current state and propose solutions to high-rate manufacturing of AAM composites.   Visit https://advancedmanufacturing.org/webinars for a more interactive experience with visuals.  SPEAKERS: Nick Gianaris, PhD, PE Principal Technical Consultant, Nexight Group Doug Decker, FSME President of the Composites Consultants Ben Dietsch VP, Arsenal, Cornerstone Research Group, Inc. Sana Elyas Industrial Collaborations-Composites Innovation & Sustainable Manufacturing Technologies, Oak Ridge National Laboratory  

Join Digital Education Committee host Jason Jacobson, MD, FHRS, as he discusses this late 2024 article with guests Miguel Valderrabano, MD, PhD, FHRS and J. Peter Weiss, MD, Msci, FHRS, from the HRSTv Studio in Atlanta at HRX 2025. The trial compared two treatment strategies for patients with ventricular tachycardia: early catheter ablation versus continuing antiarrhythmic drug therapy (mostly sotalol or amiodarone).  It found that starting with catheter ablation resulted in fewer episodes of ventricular tachycardia, less need for hospitalizations and interventions, and better overall control of arrhythmias compared to relying on drugs alone. Learning Objective: Compare early catheter ablation to continuing antiarrhythmic drug therapy as effective treatment strategies for patients with ventricular tachycardia. Article AuthorsJohn L. Sapp, M.D., Anthony S.L. Tang, M.D., Ratika Parkash, M.D., William G. Stevenson, M.D., Jeff S. Healey, M.D., Lorne J. Gula, M.D., Girish M. Nair, M.B., B.S., Vidal Essebag, M.D., Ph.D., Lena Rivard, M.D., Jean-Francois Roux, M.D., Pablo B. Nery, M.D., Jean-Francois Sarrazin, M.D., Guy Amit, M.D., Jean-Marc Raymond, M.D., Marc Deyell, M.D., Chris Lane, M.D., Frederic Sacher, M.D., Christian de Chillou, M.D., Vikas Kuriachan, M.D., Amir AbdelWahab, M.D., Isabelle Nault, M.D., Katia Dyrda, M.D., Stephen Wilton, M.D., Umjeet Jolly, M.D., Arvindh Kanagasundram, M.D., and George A. Wells, Ph.D., for the VANISH2 Study Team  Podcast Contributors Jason Jacobson, MD, FHRS | Westchester Medical Center Miguel Valderrabano, MD, PhD, FHRS Houston Methodist Hospital J. Peter Weiss, MD, Msci, FHRS | Banner University of Arizona Medical Center, Phoenix Contributor Disclosures: J. Jacobson Honoraria/Speaking/Consulting: Zoll Medical Corporation, Vektor Medical, Inc. Research: Cardio Focus Stocks, Privately Held: Atlas 5D Miguel Valderrabano, MD, PhD, FHRS Speaking/Teaching/Consulting: Biosense Webster Inc., Boston Scientific, Abbott Medical, Biotronik Research: Circa Scientific, Biosense Webster, Inc.   J. Peter Weiss, MD, Msci, FHRS Speaking/Teaching/Consulting: Abbott Medical, Biotronik, Stereotaxis, Inc., Circa Scientific, Synaptic Medical, Luma Vision Bonsu video of this episode, recorded at HRX Live 2025 in Atlanta, can be found on HRS365 and the HRX Innovation Hub

Thomas Agoritsas, MD, PhD, Geneva University Hospitals, Switzerland discusses Users' Guides to the Medical Literature about patient management recommendations with author Gordon H. Guyatt, MD, MSc, McMaster University. Related Content: How to Interpret and Use a Clinical Practice Guideline or Recommendation Platelet Transfusion Caring for Patients With Acute Respiratory Distress Syndrome

‘Change is possible' - that's the message of Doctor and Neuroscientist Brian Pennie, who is about to deliver his first talk at Maynooth University since his studies there.The university is celebrating 25 years of its Psychology Department, and is hosting a number of free events to mark the occasion, which are open to the public.The event is taking place on October 8th, and coincides with the day Dr. Brian Pennie recovered from his heroin addiction.12 years on, he has obtained a PhD and uses his platform to help people who are looking to turn their life around…He also hosts the ‘Change is Possible' podcast, which encourages everyone to pursue the very best version of themselves.Dr. Brian Pennie joins Seán to discuss.Image: @mu_psychology_ on Instagram

Join us for an enlightening journey with Roger Kuhn, a two-spirit indigenous queer artist, musician, and advocate, as we explore the intricate tapestry of identity and healing through art. Roger shares his profound connection to his roots, growing up in rural North Dakota as part of an interracial family. Listen in as he candidly discusses the challenges of being "othered" due to his racial and gender identity and how these experiences informed his healing journey and inspired his work in music, storytelling, and advocacy. Roger's unique relationship with the land and nature in North Dakota offered him a sense of belonging, and this connection remains a cornerstone of his identity and his commitment to using art as a vehicle for healing and truth-telling.In our conversation, Roger opens up about his multifaceted career, highlighting the transition from the music world to pursuing a lifelong dream of becoming a therapist. Supported by his tribal community, Roger earned a PhD and now advocates for two-spirit and native people in mental health spaces. Discover how the intersection of creativity and therapy plays a vital role in his life, offering unique insights into the healing process. Roger shares his philosophy on balancing creative pursuits with clinical work, emphasizing vulnerability and connection as essential elements that enrich both his artistic endeavors and therapeutic practice.Throughout our discussion, we delve into the pressing issues facing Two-Spirit and LGBTQ+ Indigenous communities. Roger sheds light on the challenges of accessing healthcare, the importance of decolonization, and the need for community gatherings to foster support and love. From his personal experiences in rural North Dakota to urban environments like New York and San Francisco, Roger's evolving cultural identity and dedication to advocacy shine through. He reflects on his mixed-race heritage and the stories of resilience and self-worth passed down through generations, motivating him to persist and thrive. This episode is a compelling testament to the transformative power of art, therapy, and the courage to live authentically.

Tagging hammerheads, tracking silky sharks and exploring a remote coral paradise in the middle of the Gulf of Mexico…This week, we're diving into the fascinating world of shark trophic ecology with PhD researcher and SOSF project leader Brett Sweezey! Brett is investigating the interactions between predators and prey, and how they influence where sharks go amongst the unique habitats of the Flower Garden Banks National Marine Sanctuary. Join us as we discuss the innovative methods Brett is using, some fascinating early findings, and the challenges and triumphs of studying these incredible creatures in their natural habitat. You can follow Brett across all platforms: @saltwatersweezey. You can also find out more about his project here: https://saveourseas.com/project/methods-to-reduce-shark-stress/ Shownotes: www.saveourseas.com/worldofsharks/podcast

What happens when you've done all the right things  but still feel stuck, unfulfilled, or secretly unhappy in your career?That's the story of today's guest, Manana Jaworska, a career transition coach who knows firsthand how messy and complicated career change can be.From psychology student to PhD researcher, to programmer in Barcelona with the golden handcuffs, Manana has lived through multiple career flips. On paper, everything looked perfect. But inside, she was craving meaning, freedom, and a life that felt true to her.In this episode, Manana shares:How cultural and family expectations shaped her early career choicesWhy it's so important to get real about the day-to-day reality of a job (before you jump into it)The moment she realized stability wasn't enough — and what gave her the courage to walk awayHow she now helps clients find clarity, define their values, and create careers that align with who they areWhether you're just starting to wonder if there's something more, or you're already on the edge of making a leap — this conversation will give you permission to trust that voice inside you.Connect with MananaInstagram: @careerchangeguide LinkedIn: Manana Jaworska Thanks for tuning in to The Career Flipper!If this episode made you think, laugh, or feel a little braver about your own flip, do me a favor:

Episode Description: Gabby shares her mission to support community cats in Gainesville by aiding the local trap-neuter-release operation, Operation Catnip. She highlights her efforts in building cat houses and raising awareness about the mental health benefits these community cats provide to university students, particularly at the University of Florida. Gabby explains the concept of community cats, differentiating them from feral cats, and emphasizes the positive environmental role they play. Tune in to learn more about Gabby's inspiring project The Purrr-fect Home and the importance of caring for community cats! More about Gabby: Gabrielle Ontiveros, also known as Gabby, is a sophomore at the University of Florida and a Girl Scout Alumna! She was in Girl Scouts for 10 years and officially earned her Gold Award in October of 2024 from the Gateway Council. Her Gold Award project, titled "The Purrrfect Home," targeted community cats and students in the Gainesville area. At the University of Florida she majors in Psychology (Behavioral Analysis) and minors in Media Management, Production, and Technology; outside of her classes she is involved in the UF Psychology Club, Women's Student Association, the McNair Scholars Program, and UF HOSA ,competing and placing internationally and serving as PR Director this upcoming year. Her future plans are to attend graduate school to earn a PhD. in Psychology to pursue research and teaching! Her hobbies including painting, reading, gaming, and going on adventures with her friends! linktr.ee/ThePurrrfectHome?fbclid=PAQ0xDSwL1-sFleHRuA2FlbQIxMQABp7uRiQvacGOKfVgXKHTiDp7T0NtqowkS8lRX_QV4rW_z8NRcheUPD5gUOdkY_aem_2PSYNJPBXeeqTXiwJnJozQ

The tropical waters of Sri Lanka, an island off the coast of India, are home to a population of blue whales unlike any other. These whales stay put, while every other known population migrates. That discovery was made by budding scientist Asha de Vos more than 20 years ago—it made a splash, and so did she. She later became the first Sri Lankan to earn a PhD studying marine mammals, charting a new scientific path in her country.Host Flora Lichtman talks with de Vos about her path into science, what it means to be the first Sri Lankan in her field, and how she built a marine biology program from the ground up.Guest: Dr. Asha de Vos is a marine biologist and the founder and executive director of the non-profit Oceanswell. She's based in Sri Lanka.Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

How much is your word worth? For former NBA player turned psychologist John Amaechi, the answer is $17 million. In this episode, John and Ryan unpack why he walked away from that payday, why integrity is his ultimate non-negotiable, why your job should never define you, and more. John Amaechi is an English psychologist, consultant and former professional basketball player. He played college basketball for the Vanderbilt Commodores and Penn State Nittany Lions, and professional basketball in the NBA for the Orlando Magic, Utah Jazz, and Cleveland Cavaliers. Since retiring from basketball, John got his PhD in psychology and has worked as a psychologist and consultant, establishing his company Amaechi Performance Systems.Follow John on X @JohnAmaechi and on Instagram @JohnAmaechiOBE

Tired of ADHD strategies that don't work? Here's what actually does. FREE training here: https://programs.tracyotsuka.com/signup_____Burnout was Skye Waterson's PhD companion. She'd switch majors—psychology to law to sociology—convinced each time that she just hadn't found her passion yet. The truth was simpler and more complex: she was trying to outwork her undiagnosed ADHD, and no amount of grinding harder was going to fix a brain that needed different systems entirely. By the time she finished her master's thesis, she was so burned out she couldn't even process being offered a guaranteed PhD scholarship. Instead, she worked at a bakery and took art classes until her now-husband asked the obvious question: "Wait, you did a master's? You have a scholarship? What's going on?"The ADHD diagnosis came at the perfect time—right as she was starting her PhD. Instead of seeing it as a limitation, Skye turned her academic brain toward understanding how her mind actually worked. She started researching, writing articles, and building the productivity systems that traditional advice couldn't provide. What began as survival became her calling, and eventually, her business grew so successful that her supervisors encouraged her to leave academia entirely.Now, as founder of Unconventional Organisation, Skye helps entrepreneurs, founders, and executives scale their businesses without scaling their stress. In this conversation, she and Tracy dive into why neurotypical productivity advice fails ADHD brains, how to prioritize when everything feels urgent, and Skye's game-changing approach to delegation using AI. They explore her "recipe" method for breaking down tasks, why the Pomodoro technique wasn't designed for us, and how understanding dopamine timing can revolutionize your work flow.Resources:Website: https://www.unconventionalorganisation.com Instagram: https://www.instagram.com/unconventionalorganisation LinkedIn: https://www.linkedin.com/in/skye-waterson-026286204 Send a Message: Your Name | Email | Message Instead of Struggling to figure out what to do next? ADHD isn't a productivity problem. It's an identity problem. That's why most strategies don't stick—they weren't designed for how your brain actually works. Your ADHD Brain is A-OK Academy is different. It's a patented, science-backed coaching program that helps you stop fighting your brain and start building a life that fits.

Acclaimed psychologist, behavioral finance expert, and author, Dr. Daniel Crosby, PhD* joins me this week to discuss his new book The Soul of Wealth: 50 Reflections on Money and Meaning. We cover the fun, non-obvious aspects of money and emotions, such as how comparison drives us crazy and why our bias toward action —doing something when things are going wrong — often leads to worse investment results. He offers small tips (like giving your savings account a name) that will help you save more and spend less. Daniel shares lessons from his (Mormon) mission to the Philippines, and we both reflect on how our frugal parents informed who we are today, in almost entirely (but not 100%) good ways. From the dangers of debt and overconfidence to escaping the toxic loop of “I'll be happy when…,” we cover a lot of ground and have lots of laughs along the way. Listening to these two money-talkers with great hair will improve your life! Read Paul's Substack: https://words.paulollinger.com/ Listen to Daniel's podcast, Standard Deviations: https://www.standarddeviationspod.com/episodes *don't forget the “PhD” part or he gets very mad.

Left-handers make up about 10.6 percent of the world's population. Sebastian Ocklenburg, PhD, talks about why handedness and other brain asymmetries exist; the genetic and environmental factors that influence handedness; whether there's any truth to the stereotype that lefties are more creative; why “pawedness” is common in cats, dogs, and other non human animals; and why left-handed people are underrepresented in brain research. Learn more about your ad choices. Visit megaphone.fm/adchoices

What if your own body turned against you, making you allergic to life itself? Don Dillon's career as a Navy officer was destroyed by a mysterious illness that caused hundreds of seizures, a battle that shows what real mental toughness is. In episode 819 of the Savage Perspective Podcast, host Robert Sikes talks with Don about his journey from a failed medical system to discovering the ketogenic diet. They discuss how Don used biohacking and a carnivore diet to rebuild his health and stop his seizures for good. This conversation covers how to build discipline when facing impossible odds and how Don developed a new food manufacturing process using soundwave technology to help others.If Don's story on building a strong body inspires you, then join Robert's FREE Bodybuilding Masterclass. This is your chance to learn the exact diet and training methods to build a powerful physique. Sign up here: https://www.ketobodybuilding.com/registration-2Get Keto Brick: https://www.ketobrick.com/Subscribe to the podcast: https://open.spotify.com/show/42cjJssghqD01bdWBxRYEg?si=1XYKmPXmR4eKw2O9gGCEuQChapters:0:00 - From Military Seizure to a Ketogenic Diet 0:50 - Why I Chose the Navy Over a PhD 2:23 - My Role as a Navy Surface Warfare Officer 4:21 - The Seizure That Ended My Military Career 7:25 - "Allergic to Life": The Shocking Cause of My Seizures 9:00 - The Alternative Treatment That Stopped My Severe Seizures 10:13 - Why Doctors Prescribed Drugs, Not Diet 11:49 - How I Found the Ketogenic Diet On My Own 13:01 - The Modified Ketogenic Diet I Used to Stop Seizures 14:10 - The Specific Nutrients That Changed My Life 15:10 - Is Military Food Nutritious? A Look at MREs 16:46 - What Is Soundwave Technology in Food Manufacturing? 18:48 - How to Commercialize a New Food Technology 20:00 - The Mission: Bringing Joy Back to Biohacking 21:25 - How Soundwave Technology Actually Works 22:57 - The Mind Bar: A Nootropic You Can Eat 24:41 - How to Design the Perfect Pre-Game NFL Snack 25:55 - The Brutal Reality of In-House Food Manufacturing 27:05 - Navigating the Cacao Crisis: A Switch to Beef Tallow 28:24 - Can You Build Muscle on a Ketogenic Diet? 28:48 - The Biggest Myth About Long-Term Keto 31:40 - How Long-Term Carnivore Affects Health 32:23 - What a Daily Carnivore Diet Looks Like 34:16 - Do Low-Carb Vegetables Cause Inflammation? 35:20 - Why I Switched to a Mostly Carnivore Diet 36:00 - The Dangers of Too Much Protein on a Keto Diet 38:37 - How to Determine Your Daily Fat to Protein Ratio 40:01 - What is Your Unique Protein Threshold? 41:08 - How We're Marketing a New Biohacking Product 43:21 - Should You Attend the Hack Your Health Conference? 44:14 - Raising Resilient Kids Through Adversity 46:02 - The Challenges of Being a Father and Entrepreneur 48:47 - The Future of Food Technology: Sound Bars & Keto Bricks 49:24 - Where to Find Sound.Food Products